What: Marks & Spencer launches a food range specifically designed for customers using weight-loss medications, reflecting retail innovation in health and wellness.

Why it is important: M&S’s strategy reflects a broader shift toward health and wellness in retail, reinforcing the need for specialised offerings and operational innovation.

Marks & Spencer has introduced a new food range tailored for individuals using weight-loss medications, positioning itself at the forefront of retail’s response to emerging health and wellness trends. This initiative comes as the influence of drugs like Ozempic reshapes consumer behaviour, prompting retailers to adapt their product development and inventory strategies to meet evolving dietary needs. M&S’s move demonstrates a proactive approach to capturing new demand segments, leveraging its reputation for quality and innovation to address the specific requirements of customers on weight-loss jabs. The launch is part of a broader strategy that includes accelerated food business expansion, renewed investment in wellness, and a focus on digital resilience and supply chain agility. By responding swiftly to medical and lifestyle shifts, M&S sets a benchmark for established retailers aiming to remain relevant and competitive in a rapidly changing market landscape.

IADS Notes: In January 2026, Retail Week reported on M&S’s launch of a food range for people on weight-loss jabs, highlighting retail innovation in response to health trends. Forbes in September 2025 discussed the “Ozempic effect” and its impact on consumer demand, while Drapers in November 2025 noted M&S’s accelerated food business expansion. Additional initiatives, such as the 365-day kids’ clothing guarantee (Retail Week, July 2025) and CEO Stuart Machin’s focus on digital and supply chain innovation (Drapers, September 2025), further illustrate the company’s commitment to customer-centric and operational agility.

Marks & Spencer unveils food range for people on weight-loss jabs